| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 263,340 | 27 Aug 2021 | Direct | ||
| Kymera Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 0 | $30.05 | 27 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 27 Aug 2021 | 3 | -$1,355,284 | 4 | Chief Scientific Officer | 27 Aug 2021, 16:55 |
| KYMR | Kymera Therapeutics, Inc. | 17 Aug 2021 | 6 | -$1,640,182 | 4 | Chief Scientific Officer | 19 Aug 2021, 16:30 |